Natco Pharma's Kothur facility gets 8 USFDA observations

Natco Pharma Limited has announced the completion of an inspection by the United States Food and Drug Administration (USFDA) for its Pharma Division located in Kothur Hyderabad, India.

 

According to the regulatory filing, the inspection was conducted from October 9, 2023 to October 18, 2023.

 

“At the end of the inspection, the facility received 8 observations. The company is confident of addressing all the observations within the stipulated time and working with USFDA to close them at the earliest”, Natco Pharma said on Thursday.

 

On Friday early morning trade, shares of Natco Pharma were trading lower by 0.40% at Rs 830.45 per share on the BSE.

Related Blogs
blog-logo

Share Market

blog-logo

8 mins read . 19 Jul 2024

Stock Market Trading Time in India

  • 43 people read
blog-logo

Share Market

blog-logo

11 mins read . 19 Jul 2024

How To Trade in T2T Stocks

  • 43 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions